Glaxo, Pfizer’s Hiv Treatment Recommended By Eu Regulator
The treatment, approved by the U.S. Food and Drug Administration in August, reduced the HIV virus to undetectable levels in more people than Gilead Sciences Inc. (GILD) s Atripla, the worlds best-selling AIDS drug, in a clinical trial released last year. The medicine, also known as dolutegravir, is an integrase strand transfer inhibitor that interferes with the enzymes necessary for HIV to multiply. Merck & Co. You will find the original content at this website http://www.bloomberg.com/news/2013-11-22/glaxo-pfizer-s-hiv-treatment-recommended-by-eu-regulator.html
Source: aids-write.org - Category: HIV AIDS Authors: aidswrite Tags: current news hiv news Source Type: blogs
More News: Atripla | Clinical Trials | Food and Drug Administration (FDA) | HIV AIDS | Merck | Pfizer | Websites